PKD Foundation

PKD Foundation

非盈利组织

Kansas City,Missouri 4,304 位关注者

We give hope. We fund research, advocate for patients and build a community for all impacted by PKD.

关于我们

The PKD Foundation is a not-for-profit organization dedicated to finding treatments and a cure for polycystic kidney disease (PKD). Our mission: We give hope. We fund research, advocate for patients and build a community for those affected by PKD. Our vision: #endPKD The PKD Foundation founded in 1982 by Joseph H. Bruening and Jared J. Grantham, M.D., and is headquartered in Kansas City, MO PKD Connect: Whether you are looking for information, resources or just a shoulder to lean on, PKD Connect gives you the support to keep hope within reach. Visit PKD Connect at connect.pkdcure.org

网站
https://www.pkdcure.org
所属行业
非盈利组织
规模
11-50 人
总部
Kansas City,Missouri
类型
非营利机构
创立
1982
领域
fundraising、advocacy、awareness、education、lifestyle、health、donation和charity

地点

  • 主要

    1001 E. 101st Terr

    Suite 220

    US,Missouri,Kansas City,64131

    获取路线

PKD Foundation员工

动态

  • PKD Foundation转发了

    查看Kristen O'Shea, M.Ed.的档案,图片

    ??Development Coach | Speaker - Business Owner - State Senator

    "I learned my strengths are necessary for building a strong team." "Had great conversations around balancing our strengths." "I am now able to be more future oriented." "Knowing how to prevent myself from going to the basement side of my strengths." Just a few things shared from the PKD Foundation team Strengths workshop today. Many flew into Kansas City for in-person team time this week. And a shout out to Ewing Marion Kauffman Foundation for having a mothering room! Susan Bushnell Carmen Gleason Tanya Bissen Krystn Kuckelman Caitlin Lasky Laura Rayburn Monica Pontarelli Nicole Harr Becky Conelias Savanna Moore Sydney Johnston Vanessa Holliday

    • 该图片无替代文字
    • 该图片无替代文字
  • 查看PKD Foundation的公司主页,图片

    4,304 位关注者

    Denver, Houston, and Philadelphia! We’re looking for passionate PKD Connect Ambassadors in these communities. Our Ambassadors play a vital role in supporting patients on their PKD journey by connecting them to PKD Foundation programs, services, educational resources, and more. Learn how to get involved at https://lnkd.in/g_F4wdad

    • 该图片无替代文字
  • 查看PKD Foundation的公司主页,图片

    4,304 位关注者

    Meet kidney researcher Duuamene Nyimanu, Ph.D., of the University of Kansas Medical Center. In 2023 he received a fellowship to investigate whether targeting the apelin signaling pathway system could slow the progression of PKD. Apelin receptors are found in blood vessels and various organs, including the kidneys. When activated by apelin proteins, they trigger responses such as blood vessel relaxation and reduced inflammation. Although Dr. Nyimanu initially focused on their role in cardiovascular disease, he became intrigued by their actions in the kidneys. His research turned up three published studies in ADPKD, but all indicated that decreased apelin signaling accelerated PKD progression. In one study, PKD patients with the lowest apelin levels developed worse disease over 12 months. They also had increased injury to the tubules, the kidney structures that filter urine. This suggested that boosting apelin activity might protect kidney function. Though apelin receptors remain intact in PKD, levels of the apelin ligands that activate them are reduced. By replacing the missing apelin proteins, Dr. Nyimanu hopes to reconstitute signaling and slow cyst growth and kidney damage. If successful in animals, the goal is to translate these findings into apelin-based drugs for human PKD, Dr. Nyimanu says. Beyond potential kidney benefits, the apelin system also lowers blood pressure—a major complication in PKD. Activating apelin receptors could thus provide the dual advantages of preserving kidney function while controlling hypertension and its accompanying risks of cardiovascular disease and stroke. Learn more about PKD Foundation-funded research at https://lnkd.in/gUDdu3i.

    • 该图片无替代文字

相似主页

查看职位